| 前收市價 | 9.15 |
| 開市 | 9.15 |
| 買盤 | 6.80 |
| 賣出價 | 8.50 |
| 拍板 | 40.00 |
| 到期日 | 2024-12-20 |
| 今日波幅 | 9.15 - 9.15 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 801 |
Investor's Business DailyHalozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating
Halozyme Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 84.
ZacksHere's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ZacksAre You a Value Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
